US Patent Issued to Janssen Pharmaceutica on July 14 for "Cyclin-dependent kinase 7 (CDK7) non-covalent inhibitors" (French, Belgian Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,839, issued on July 14, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium).

"Cyclin-dependent kinase 7 (CDK7) non-covalent inhibitors" was invented by Laurence Anne Mevellec (Issy-les Moulineaux, France), Sophie Coupa ep. Descamps (Issy-les Moulineaux, France), Christiphe Denis Pascal Adelinet (Issy-les Moulineaux, France), Yannick Aime Eddy Ligny (Issy-les Moulineaux, France), Christophe Meyer (Issy-les Moulineaux, France) and Ian Stansfield (Beerse, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to pharmaceutical compounds of formula (I) and pharmaceutical compositions comprising said compounds, to processes f...